JCB, Volume 20, Number 3, 2014 Commentary Vol.20 No. 3 (2014) Who Lost Opioids? Peter J. Pitts Commentary Vol.20 No. 3 (2014) GM tea: the need of the hour to reclaim India’s leading position in the global tea market Debajit Borah Article Vol.20 No. 3 (2014) What makes a happy team? Data from 5 years’ entrepreneurship teaching suggests that working style is a major determinant of team contentment. William Bains I report on five years’ testing of what makes a happy team, using students in a Bioscience Entrepreneurship Masters programme at Cambridge University as a test-bed. I looked at mea Article Vol.20 No. 3 (2014) Ethical, Legal, and Regulatory Issues Regarding the Study and Use of Medications in Pregnant Women Diana Pham Despite the prevalence of off-label drug prescriptions for pregnant women, little attention is paid to the ethical, legal, and regulatory issues regarding this practice. This paper discus From the Classroom Vol.20 No. 3 (2014) The University of Colorado Digital Health Consortium Initiative: A Collaborative Model of Education, Research and Service Jiban Khuntia This article describes the initiative and actions related to establishing a Digital Health Consortium (DHC) at the University of Colorado Denver. The consortium is a part of the Center fo Legal and Regulatory Updates Vol.20 No. 3 (2014) Staking an Advantage in an AIA World: Practical Patent Tips for Biotechnology Companies Stefan Michael Miller With passage of the Leahy-Smith America Invents Act (AIA), new rules and procedures related t Legal and Regulatory Updates Vol.20 No. 3 (2014) USPTO Guidance On Patentable Subject Matter: Impediment to Biotech Innovation? Joanna T. Brougher In June 2013, the U.S. Supreme Court issued a unanimous decision upending more than three decades worth of established patent practice when it ruled that isolated gene sequences are Legal and Regulatory Updates Vol.20 No. 3 (2014) EU Legal & Regulatory Update – June 2014 Ewan Grist Conference Report Vol.20 No. 3 (2014) Four Perspectives on Business Model Evolution in Synthetic Biology Karl Schmieder Book Review Vol.20 No. 3 (2014) India's Healthcare Industry: Innovation in Delivery, Financing, and Manufacturing Susan Finston
